Effect of Face Mask on Tear Film Stability in Eyes With Moderate-to-Severe Dry Eye Disease.
Adult
Aged
Aged, 80 and over
Cross-Sectional Studies
Cyclosporine
/ administration & dosage
Dry Eye Syndromes
/ drug therapy
Female
Humans
Immunosuppressive Agents
/ administration & dosage
Lubricant Eye Drops
/ administration & dosage
Male
Masks
Middle Aged
Slit Lamp Microscopy
Tears
/ physiology
Visual Acuity
/ physiology
Journal
Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186
Informations de publication
Date de publication:
01 Oct 2021
01 Oct 2021
Historique:
received:
19
12
2020
accepted:
18
02
2021
entrez:
4
9
2021
pubmed:
5
9
2021
medline:
18
12
2021
Statut:
ppublish
Résumé
The purpose of this study was to evaluate whether tear film stability worsens with the use of masks in patients with dry eye disease, objectively analyzing the tear film stability using noninvasive tear film breakup time (NITBUT) with and without a face mask. A cross-sectional study including patients with moderate or severe dry eye disease was conducted. Tear stability was measured using an Oculus Keratograph 5M (Oculus, Wetzlar, Germany), which records NITBUT, both first and average NITBUT. Two measurements were taken: an initial measurement with a mask and a second measurement after 10 minutes without wearing the face mask. Thirty-one patients were included with a mean age of 57.6 ± 11.7 years (range 31-80) and 30 being female (97%). Mean first NITBUT with face mask was 6.2 ± 3.8 seconds (range 2.0-19.8), which increased to 7.8 ± 5.6 seconds (range 2.3-24.0) without the use of mask (P = 0.029), differences being -1.6 ± 0.7 seconds (CI 95% -3.1075 to -0.1770). Mean average NITBUT with a face mask was 12.3 ± 4.8 seconds (range 4.0-19.4) and increased to 13.8 ± 5 seconds (range 5.5-24.0) without the use of mask (P = 0.006), mean difference being -1.5 ± 0.5 seconds (CI 95% -2.5290 to -0.4458). Face mask use decreases tear film stability in patients with moderate-to-severe dry eye.
Identifiants
pubmed: 34481410
doi: 10.1097/ICO.0000000000002734
pii: 00003226-202110000-00016
doi:
Substances chimiques
Immunosuppressive Agents
0
Lubricant Eye Drops
0
Cyclosporine
83HN0GTJ6D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1336-1339Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264–1268.
McCarty CA, Bansal AK, Livingston PM, et al. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105:1114–1119.
Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea. 2004;23:272–285.
Desai AN, Aronoff DM. Masks and coronavirus disease 2019 (COVID-19). JAMA. 2020;323:2103.
Moshirfar M, West WB, Marx DP. Face mask-associated ocular irritation and dryness. Ophthalmol Ther. 2020;9:397–400.
Giannaccare G, Vaccaro S, Mancini A, et al. Dry eye in the COVID-19 era: how the measures for controlling pandemic might harm ocular surface. Graefe's Arch Clin Exp Ophthalmol. 2020;258:2567–2568.
Wang MTM, Craig JP. Comparative evaluation of clinical methods of tear film stability assessment a randomized crossover trial. JAMA Ophthalmol. 2018;136:291–294.
Hong J, Sun X, Wei A, et al. Assessment of tear film stability in dry eye with a newly developed keratograph. Cornea. 2013;32:716–721.
Tian L, Qu JH, Zhang XY, et al. Repeatability and reproducibility of noninvasive keratograph 5m measurements in patients with dry eye disease. J Ophthalmol. 2016;2016:8013621.
Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15:539–574.
Fuller DG, Potts K, Kim J. Noninvasive tear breakup times and ocular surface disease. Optom Vis Sci. 2013;90:1086–1091.
Hayirci E, Yagci A, Palamar M, et al. The effect of continuous positive airway pressure treatment for obstructive sleep apnea syndrome on the ocular surface. Cornea. 2012;31:604–608.
Harrison W, Pence N, Kovacich S. Anterior segment complications secondary to continuous positive airway pressure machine treatment in patients with obstructive sleep apnea. Optometry. 2007;78:352–355.
Singh NP, Walker RJE, Cowan F, et al. Retrograde air escape via the nasolacrimal system: a previously unrecognized complication of continuous positive airway pressure in the management of obstructive sleep apnea. Ann Otol Rhinol Laryngol. 2014;123:321–324.
Powell JB, Kim JH, Roberge RJ. Powered air-purifying respirator use in healthcare: effects on thermal sensations and comfort. J Occup Environ Hyg. 2017;14:947–954.
Dennis RJ, Miller RE, Peterson RD, et al. Contact lens wear with the USAF Protective Integrated Hood/Mask chemical defense ensemble. Aviat Space Environ Med. 1992;63:565–571.
Lazzarino AI, Steptoe A, Hamer M, et al. Covid-19: important potential side effects of wearing face masks that we should bear in mind. BMJ. 2020;369:m2003.
Narayanan S, Redfern RL, Miller WL, et al. Dry eye disease and microbial keratitis: is there a connection? Ocul Surf. 2013;11:75–92.
Campione E, Cosio T, Rosa L, et al. Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation. Int J Mol Sci. 2020;21:4903.
Güemes-Villahoz N, Burgos-Blasco B, Vidal-Villegas B, et al. Novel insights into the transmission of SARS-CoV-2 through the ocular surface and its detection in tears and conjunctival secretions: a review. Adv Ther. 2020;37:4086–4095.